Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? Formal Study

Sponsor
Sue Ryder Care (Other)
Overall Status
Unknown status
CT.gov ID
NCT00550251
Collaborator
(none)
58
1
2
96
0.6

Study Details

Study Description

Brief Summary

Pilot study completed - power calculation performed. Now formal double blind randomized study comparing active with placebo wristbands for nausea in palliative care patients to be carried out.

Condition or Disease Intervention/Treatment Phase
  • Device: Acupressure Wrist Bands (Sea-Bands)
  • Device: Placebo wristbands
N/A

Detailed Description

Terminally ill hospice in-patients suffering with nausea will be randomized to active or placebo acupressure bands. The study will last 3 days and they will be allowed to continue regular or have PRN anti-emetics during the study.

Assessors and patients will both be blinded to whether they patients are receiving active or placebo bands.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
58 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? Formal Study
Study Start Date :
Jul 1, 2010
Anticipated Primary Completion Date :
Jul 1, 2018
Anticipated Study Completion Date :
Jul 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Acupressure Bands

Elasticated wrist bands with active bead pressing on Pericardium 6 acupressure points bilaterally.

Device: Acupressure Wrist Bands (Sea-Bands)
Elasticated wrist bands with active bead pressing on Pericardium 6 acupressure points bilaterally.
Other Names:
  • Sea-Bands
  • Placebo Comparator: Placebo

    Elasticated wrist bands without active bead.

    Device: Placebo wristbands
    Elasticated wrist bands without active bead.
    Other Names:
  • Seaband Placebo
  • Outcome Measures

    Primary Outcome Measures

    1. Number of PRN Doses of anti-emetics needed [3 days]

    Secondary Outcome Measures

    1. Visual Analogue Scale of nausea; duration of perceived nausea; number of vomits per 24 hours; volume of vomit per 24 hours; adverse effects of acupressure; measure of whether the patient felt the intervention helped. [3 days]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Have a diagnosis of advanced cancer with an estimated prognosis of less than 1 year but more than 3 days.

    2. Describe their nausea as at least moderate on a Likert scale OR at have had at least one vomit per day for the last three days.

    3. Have an underlying cause for their nausea which is thought to be irreversible OR the patient has made an autonomous choice not to proceed with treatment for any potentially reversible cause (for example surgery for obstruction or drainage of ascites).

    4. Can be male or female patients but must be over the age of 18.

    5. Have signed a consent form prior to entering the study.

    6. If patients are taking corticosteroids the dosage should be stable for 3 days before and during the trial.

    7. Be thought to be well enough to complete the 3 day trial.

    Exclusion criteria:
    1. Arm lymphoedema.

    2. Weakness, fatigue or confusion sufficient that patient is unable to take part.

    3. Previous history of acupuncture/acupressure for nausea or vomiting, or history of use of acupressure by a close relative.

    4. History of Parkinsonism or Parkinsonism on examination.

    5. Patients will not be enrolled if they are sharing a room with another patient taking part in the study.

    6. Patients who are unable to read or comprehend the questionnaire or Visual Analogue Scale.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sue Ryder Care Leckhampton Court Hospice Cheltenham Gloucestershire United Kingdom GL53 0QJ

    Sponsors and Collaborators

    • Sue Ryder Care

    Investigators

    • Study Director: Paul Perkins, MB Bch MRCP, Sue Ryder Care Leckhampton Court Hospice

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Paul Perkins, Consultant in Palliative Medicine, Sue Ryder Care
    ClinicalTrials.gov Identifier:
    NCT00550251
    Other Study ID Numbers:
    • SRC2
    First Posted:
    Oct 29, 2007
    Last Update Posted:
    May 4, 2018
    Last Verified:
    May 1, 2018
    Keywords provided by Paul Perkins, Consultant in Palliative Medicine, Sue Ryder Care
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 4, 2018